Improved Method for Detecting Circulating Tumor Cells in Breast Cancer
Author Information
Author(s): Deng Glenn, Herrler Michael, Burgess David, Manna Edward, Krag David, Burke Julian F
Primary Institution: Genetix USA Inc
Hypothesis
Can an anti-CK antibody-based method improve the detection of circulating tumor cells (CTCs) in metastatic breast cancer patients compared to traditional methods?
Conclusion
The anti-CK antibody-based method significantly enhances the sensitivity of CTC detection in metastatic breast cancer patients.
Supporting Evidence
- Our method detected 49% of patients with at least one CTC compared to 29% with the CellSearch™ system.
- The dynamic range of CTC detection was significantly wider with our method (1 to 571) compared to CellSearch™ (1 to 270).
- Patients with higher CTC counts showed a 15% to 111% increase in detection using our method.
Takeaway
This study found a better way to find cancer cells in the blood of breast cancer patients, which helps doctors see how the cancer is doing.
Methodology
Blood samples from 49 metastatic breast cancer patients were processed using a new CTC assay method with anti-CK and anti-EpCAM antibodies, compared to the CellSearch™ system.
Potential Biases
Potential bias due to the comparison with a single reference method (CellSearch™) and the subjective nature of image analysis.
Limitations
The study did not explore the performance of the method in patients with low CTC counts or the potential for false positives.
Participant Demographics
All participants were metastatic breast cancer patients over 18 years of age.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website